Literature DB >> 15472315

Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens.

Jann-Yuan Wang1, Li-Na Lee, Chin-Sheng Chou, Chung-Yi Huang, Shu-Kuan Wang, Hsin-Chih Lai, Po-Ren Hsueh, Kwen-Tay Luh.   

Abstract

The performance of a nested PCR-based assay (the RAPID BAP-MTB; AsiaGen, Taichung, Taiwan) and the BD ProbeTec ET (DTB) system (Becton Dickinson, Sparks, Md.) for detection of Mycobacterium tuberculosis was evaluated with 600 consecutive clinical samples. These samples, including 552 respiratory specimens and 48 nonrespiratory specimens, were collected from 333 patients treated at National Taiwan University Hospital from September to October 2003. The results of both assays were compared to the gold standard of combined culture results and clinical diagnosis. The overall sensitivity and specificity of the RAPID BAP-MTB assay for respiratory specimens were 66.7% and 97.2%, respectively, and for the DTB assay they were 56.7% and 95.3%, respectively. The positive and negative predictive values for the RAPID BAP-MTB were 74.1% and 96.0%, respectively, and for the DTB assay they were 59.6% and 94.7%, respectively. For smear-negative samples, the sensitivity of the RAPID BAP-MTB and DTB assays was 57.1% and 40.5%, respectively. The RAPID BAP-MTB assay produced 14 false-positive results in 14 samples, including one of the six samples yielding Mycobacterium abscessus, one of the six samples yielding Mycobacterium avium intracellulare, one sample from a patient with a history of pulmonary tuberculosis with complete treatment, and three samples from three patients with a previous diagnosis of tuberculosis who were under treatment at the time of specimen collection. Among the 48 nonrespiratory specimens, the RAPID BAP-MTB assay was positive in one biopsy sample from a patient with lumbar tuberculous spondylitis and one pus sample from a patient with tuberculous cervical lymphadenopathy. Our results showed that the RAPID BAP-MTB assay is better than the DTB assay for both respiratory specimens and nonrespiratory specimens. The overall time for processing this assay is only 5 h. In addition, its diagnostic accuracy in smear-negative samples is as high as in smear-positive samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472315      PMCID: PMC522346          DOI: 10.1128/JCM.42.10.4599-4603.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Evaluation of three commercial detection systems for Mycobacterium tuberculosis where clinical diagnosis is difficult.

Authors:  T J Brown; E G Power; G L French
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study.

Authors:  Gianna Mazzarelli; Laura Rindi; Paola Piccoli; Claudio Scarparo; Carlo Garzelli; Enrico Tortoli
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis.

Authors:  J S Bergmann; W E Keating; G L Woods
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Rapid detection of pulmonary tuberculosis using the BDProbeTEC ET Mycobacterium tuberculosis Complex Direct Detection Assay (DTB).

Authors:  Tsi-Shu Huang; Wen-Kuei Huang; Susan Shin-Jung Lee; Hui-Zin Tu; Shu-Huei Chang; Yung-Ching Liu
Journal:  Diagn Microbiol Infect Dis       Date:  2003-05       Impact factor: 2.803

5.  Clinical Evaluation of the Gen-Probe amplified mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens.

Authors:  G L Woods; J S Bergmann; N Williams-Bouyer
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens.

Authors:  Claudio Piersimoni; Claudio Scarparo; Paola Piccoli; Alessandra Rigon; Giuliana Ruggiero; Domenico Nista; Stefano Bornigia
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory.

Authors:  Cathal E O'Sullivan; David R Miller; Peggy S Schneider; Glenn D Roberts
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

8.  Evaluation of the BDProbeTec ET DTB assay(1) for direct detection of Mycobacterium tuberculosis complex from clinical samples.

Authors:  J Maugein; J Fourche; S Vacher; C Grimond; C Bebear
Journal:  Diagn Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.803

9.  Performance of an IS6110-based PCR assay and the COBAS AMPLICOR MTB PCR system for detection of Mycobacterium tuberculosis complex DNA in human lymph node samples.

Authors:  Dagmar Rimek; Sachin Tyagi; Reinhard Kappe
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay.

Authors:  Sonia H Montenegro; Robert H Gilman; Patricia Sheen; Rosa Cama; Lucy Caviedes; Terryl Hopper; Richard Chambers; Richard A Oberhelman
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

View more
  25 in total

1.  Performance assessment of a novel two-step multiple displacement amplification-PCR assay for detection of Mycobacterium tuberculosis complex in sputum specimens.

Authors:  Na Wu; Yuanyuan Zhang; Jun Fu; Ruifen Zhang; Lan Feng; Yongfei Hu; Xiaoliang Li; Na Lu; Xiuqin Zhao; Yuanlong Pan; Jing Li; Baoli Zhu; Kanglin Wan
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

Review 2.  Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Authors:  S Greco; E Girardi; A Navarra; C Saltini
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

3.  Evaluation of rapid GeneXpert MTB/RIF method using DNA tissue specimens of vertebral bones in patients with suspected spondylitis TB.

Authors:  Muhammad Nasrum Massi; Karya Triko Biatko; Irda Handayani; Muhammad Yogi Pratama; Sari Septriani; Gaby Maulida Nurdin; Marina B Ali
Journal:  J Orthop       Date:  2017-01-09

4.  Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.

Authors:  J-Y Wang; P-R Hsueh; I-S Jan; L-N Lee; Y-S Liaw; P-C Yang; K-T Luh
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

5.  Direct detection and identification of Mycobacterium tuberculosis and Mycobacterium bovis in bovine samples by a novel nested PCR assay: correlation with conventional techniques.

Authors:  A Mishra; A Singhal; D S Chauhan; V M Katoch; K Srivastava; S S Thakral; S S Bharadwaj; V Sreenivas; H K Prasad
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000-2008.

Authors:  W-L Liu; C-C Lai; C-K Tan; S-H Lin; Y-T Huang; C-H Liao; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-22       Impact factor: 3.267

7.  Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Authors:  Chin-Chung Shu; Jann-Tay Wang; Chih-Hsin Lee; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

8.  Lower gastrointestinal tract tuberculosis: an important but neglected disease.

Authors:  Pei-Ying Lin; Jann-Yuan Wang; Po-Ren Hsueh; Li-Na Lee; Cheng-Hsiang Hsiao; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571

9.  Performance assessment of the DR. MTBC Screen assay and the BD ProbeTec ET system for direct detection of Mycobacterium tuberculosis in respiratory specimens.

Authors:  Jann-Yuan Wang; Li-Na Lee; Hsiao-Leng Hsu; Po-Ren Hsueh; Kwen-Tay Luh
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma.

Authors:  Jann-Yuan Wang; Chien-Hong Chou; Li-Na Lee; Hsiao-Leng Hsu; I-Shiow Jan; Po-Ren Hsueh; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.